Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study. J of Skin [Internet]. 2018 Dec. 17 [cited 2025 Apr. 19];2:S64. Available from: https://skin.dermsquared.com/skin/article/view/460